Success Stories: NIW Success for Associate Professor in Pharmaceutics Focused on Improving Drug Safety and Efficacy

Posted by wegreened on July 21, 2025 in NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

“Thank you for your efforts and support!"

On May 16^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Professor in the Field of Pharmaceutics (Approval Notice).

General Field: Pharmaceutics

Position at the Time of Case Filing: Associate Professor

Country of Origin: Saudi Arabia

Country of Residence at the Time of Filing: Egypt

Approval Notice Date: May 16^th, 2025

Processing Time: 1 year, 4 months, 20 days

Case Summary:

Our client is a highly regarded expert in pharmaceutics, focusing on drug nano-delivery systems, pharmaceutical technology, and the development of smart and sustainable alternative drug dosage forms and administration routes. His research aims to significantly improve the deliverability, targetability, efficacy, and safety of pharmaceutical drugs, addressing critical needs in drug formulation and patient care.

His body of work has garnered considerable attention and impact in the scientific community:

● 14 peer-reviewed journal articles, including 1 first-authored, 1 book chapter contributing to key topics in pharmaceutical sciences

● 2 granted patents, reflecting innovative contributions to drug delivery technologies

● 974 citations, highlighting the wide recognition and influence of his research

● At least 36 peer reviews conducted, demonstrating his expertise and active role in shaping the field

NAILG provided essential guidance throughout the NIW petition process, ensuring that our client’s scientific contributions and the national importance of his work were clearly communicated. Our strategic approach emphasized how his advancements in sustainable drug delivery and novel dosage forms align with the United States’ priorities in public health and pharmaceutical innovation.

An expert praised his work:

“[Client] is a top-tier pharmaceutics researcher. He has proven his expertise through his impactful research into in vitro and in vivo methodologies, sustainable alternative drug dosage forms, and drug delivery systems and carriers, as well as his publications in highly reputable journals. Thus, [client] 's record of achievement to date more than evidences the indispensability of his research to the United States.”

We appreciate our client’s trust in NAILG to navigate this complex process and are proud to have helped secure his NIW approval, enabling him to continue advancing critical innovations in drug delivery and pharmaceutical technology for the benefit of the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%